Ovid Therapeutics Stock Forward View - Price Action Indicator

OVID Stock  USD 2.14  0.23  12.04%   
Forecasting Ovid Therapeutics stock price is inherently uncertain, but structured approaches to analyzing market sentiment can improve the odds. This module tracks the noise around Ovid Therapeutics to identify periods where price and perception diverge.
Based on the latest data, the 14-period RSI for Ovid Therapeutics stands at 66, reflecting strengthening positive momentum. This range suggests continued bullish bias without reaching extreme statistical levels.
Momentum 66
 Buy Stretched
 
Oversold
 
Overbought
Forecasting Ovid Therapeutics stock price is inherently uncertain, but structured approaches to analyzing market sentiment can improve the odds. This module tracks the noise around Ovid Therapeutics to identify periods where price and perception diverge. Key fundamentals behind Ovid Therapeutics' forecast context:
 EPS Estimate Next Quarter
-0.09
 EPS Estimate Current Year
-0.45
 EPS Estimate Next Year
-0.37
 Wall Street Target Price
4.049
 EPS Estimate Current Quarter
-0.15
The hype perspective for Ovid Therapeutics maps headline activity to recent price response and peer coverage. Sentiment context for Ovid Therapeutics is drawn from options positioning and short interest patterns.
Refer to Days Sales Outstanding and Ptb Ratio for expanded analysis.
Ovid Therapeutics Implied Volatility
    
  2.55  
For option buyers, high Ovid Therapeutics' implied volatility means paying more for the right to profit from price movements in Ovid Therapeutics. For sellers, elevated implied volatility creates opportunities to collect richer premiums.
Ovid Therapeutics after-hype prediction price
    
  USD 1.91  
Sentiment metrics here complement forecasting and technical views with analyst and earnings context.
Historical Fundamental Analysis of Ovid Therapeutics can be used to cross-verify projections for Ovid Therapeutics. The view provides historical context for the projection set.
New to investing in Ovid Stock? Start with our How to Invest in Ovid Stock guide for a step-by-step overview.

Rule 16 Overview for current Ovid contract - Volatility Context

Rule 16 applies implied volatility to estimate a daily move of roughly 0.16% across the 2026-04-17 option cycle. With Ovid Therapeutics trading near USD 2.14, that translates to about USD 0.003411 per day in either direction.

Open Interest Snapshot: Ovid 2026-04-17 Options

Outstanding option contracts for Ovid Therapeutics are summarized through open interest, which highlights market participation.

Ovid Therapeutics Additional Predictive Modules

Most predictive techniques to examine Ovid price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Ovid using various technical indicators. When you analyze Ovid charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Ovid Therapeutics has current Price Action Indicator of 0.3. Price Action indicator evaluates an asset for a given trading period using the following formula: ((close - open) + (close - high) + (close - low)) / 2. This indicator is consistent with the interpretation of Japanese candlestick patterns.
Check Ovid Therapeutics VolatilityBacktest Ovid TherapeuticsInformation Ratio  

Ovid Therapeutics Trading Date Momentum

On March 09 2026 Ovid Therapeutics was traded for 2.14 at the closing time. The top price for the day was 2.14 and the lowest listed price was 1.78 . There was no trading activity during the period 0.0. Lack of trading volume on March 9, 2026 did not cause price change. The trading delta at closing time against the current closing price is -10.75% .
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
Compare Ovid Therapeutics to competition

Other Forecasting Options for Ovid Therapeutics

Regardless of investment experience, understanding Ovid Therapeutics' price movement is essential for anyone considering a position in Ovid. Price charts for Ovid Stock are often filled with noise that can lead to poor investment choices if not properly filtered.

Ovid Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ovid Therapeutics stock to make a market-neutral strategy. Peer analysis of Ovid Therapeutics could also be used in its relative valuation, which is a method of valuing Ovid Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Ovid Therapeutics Market Strength Events

Market strength indicators for Ovid Therapeutics give investors insight into the stock's responsiveness to broader market forces. Tracking these indicators helps investors make informed timing decisions and identify periods where trading Ovid Therapeutics is likely to be most rewarding.

Ovid Therapeutics Risk Indicators

A thorough review of Ovid Therapeutics' risk indicators is an important first step in forecasting its price and managing investment exposure. This analysis helps investors determine the appropriate level of risk to accept when holding Ovid Therapeutics'.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Story Coverage note for Ovid Therapeutics

Coverage intensity for Ovid Therapeutics matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.

Ovid Therapeutics Short Properties

Short sentiment tied to Ovid Therapeutics matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
Common Stock Shares Outstanding70.9 M
Cash And Short Term Investments53.1 M

More Resources for Ovid Stock Analysis

Understanding Ovid Therapeutics typically begins with financial statements and long-term trend review. Ratio context helps frame profitability, efficiency, and growth trends for Ovid Therapeutics Stock. Outlined below are key reports that provide context for Ovid Therapeutics Stock:
Historical Fundamental Analysis of Ovid Therapeutics can be used to cross-verify projections for Ovid Therapeutics. The view provides historical context for the projection set.
New to investing in Ovid Stock? Start with our How to Invest in Ovid Stock guide for a step-by-step overview.
Analysis related to Ovid Therapeutics should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
 Earnings Share
-0.50
 Revenue Per Share
0.093
 Quarterly Revenue Growth
-0.24
 Return On Assets
-0.29
 Return On Equity
-0.60
Ovid Therapeutics market price can diverge from book value, the accounting figure shown on Ovid balance sheet. Intrinsic value represents an estimate of underlying worth and can differ from both market price and book value. Market price can move with sentiment, cycles, and liquidity conditions, so it may drift away from fundamentals. Valuation methods compare these perspectives to frame context.
It is useful to distinguish Ovid Therapeutics' value from its trading price, which are computed with different methods. Analysis often considers earnings, revenue quality, fundamentals, technical signals, competition, and analyst coverage. The quoted price is simply the exchange level where supply meets demand.